How to Bet Big Against Obamacare

You can put money on your political beliefs and invest in (or against) the health care law’s success.

NEW YORK, NY - JANUARY 27: Traders work on the floor of the New York Stock Exchange on January 27, 2014 in New York City. Following a drop of over 300 points on Friday, U.S. markets stabilized in early trading January 27, with the Dow Jones industrial average and the S&P 500 up slightly.
National Journal
Clara Ritger
See more stories about...
Clara Ritger
Jan. 28, 2014, 8 a.m.

Think Obama­care is go­ing to fail? Now you can you put your money where your mouth is.

A Sil­ic­on Val­ley start-up called Mo­tif In­vest­ing has cre­ated a way for in­vestors to es­sen­tially bet on the law’s fail­ure: It’s selling an in­vest­ment port­fo­lio full of firms that stand to reap big be­ne­fits if the law is re­pealed or col­lapses in im­ple­ment­a­tion.

It is also of­fer­ing an op­tion for in­vestors of the op­pos­ite per­sua­sion: a re­cip­roc­al port­fo­lio of com­pan­ies that stand to prosper un­der the new health care re­gime.

Mo­tif In­vest­ing used al­gorithms to pick a sub­set of stocks in the in­dex, giv­ing con­sumers who in­vest in Obama­care a cross-sec­tion of the in­dus­tries that will profit from more in­sured Amer­ic­ans and the cost-con­tain­ment pro­vi­sions of the health care law. Con­sumers who in­vest in “Re­peal Obama­care” get a se­lec­tion of com­pan­ies in in­dus­tries that faced big cuts from the law.

The “bet­ting-on-fail­ure” bas­ket of stocks is heavy in­to com­pan­ies that do dia­gnostics, cre­ate med­ic­al devices, and provide as­sisted liv­ing for seni­ors. The pro-Obama­care port­fo­lio is made up largely of phar­ma­cies, hos­pit­als, gen­er­ic drug com­pan­ies, and elec­tron­ic med­ic­al re­cord com­pan­ies.

“There is bi­par­tis­an sup­port around re­peal­ing the ex­cise tax on med­ic­al devices,” said Hardeep Walia, CEO and former Mi­crosoft ex­ec­ut­ive. “So there doesn’t have to be a full re­peal to see a be­ne­fit to some of these in­dus­tries.”

In the­ory, both stock groups could do well at the same time. But the most in­ter­est­ing trend Walia has ob­served is how the ex­pir­a­tion of the drug pat­ent cliffs and the Af­ford­able Care Act’s pro­vi­sions pro­mot­ing lower drug costs have caused gen­er­ic-drug stocks to soar.

Mo­tif In­vest­ing of­fers oth­er spe­cial­ized port­fo­li­os, such as Gay-Friendly Com­pan­ies, Kings of K Street (com­pan­ies that spend the highest per­cent­age of their money on lob­by­ing), and No-Glass Ceil­ing (wo­men-led cor­por­a­tions).

“Do wo­men make bet­ter CEOs?” Walia asks. “Are gay-friendly com­pan­ies more likely to suc­ceed than non-gay-friendly com­pan­ies?”

You can bet on it.

What We're Following See More »
More People Watched Trump’s Acceptance Speech
20 hours ago

Hillary Clinton hopes that television ratings for the candidates' acceptance speeches at their respective conventions aren't foreshadowing of similar results at the polls in November. Preliminary results from the networks and cable channels show that 34.9 million people tuned in for Donald Trump's acceptance speech while 33.3 million watched Clinton accept the Democratic nomination. However, it is still possible that the numbers are closer than these ratings suggest: the numbers don't include ratings from PBS or CSPAN, which tend to attract more Democratic viewers.